Vimarsana
Biggest News Aggregation in the World

Page 30 - Vitro Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vitro Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vitro Diagnostics Today - Breaking & Trending Today

PredictMedix Inc.: Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia - Vimarsana News

PredictMedix Inc.: Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia

The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix's Safe Entry for regulatory approval listed as a 'Medical Device'Medical device classification allows Predictmedix

3 Disease Trends Growing Molecular Diagnostics Beyond COVID-19, reports Kalorama Information - Vimarsana News

3 Disease Trends Growing Molecular Diagnostics Beyond COVID-19, reports Kalorama Information

Arlington, VA (PRWEB) February 15, 2023 -- COVID-19 is not over, but test sales are clearly on the decline, and in vitro diagnostic (IVD) companies for the

Source: prweb.com
In Vitro Diagnostics Global Market Report 2023: Advances in Molecular Diagnostics Transforming the F - Vimarsana News

In Vitro Diagnostics Global Market Report 2023: Advances in Molecular Diagnostics Transforming the F

DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.The global in vitro diagnostics market size is expected to grow at a CAGR of 3.26% during 2022-2028. The IVD market offers advanced, cost-effective, and fast too...

Advicenne and SPA Announce an Exclusive Distribution Agreement for the Marketing of Sibnayal in Italy, Spain and Portugal - Vimarsana News

Advicenne and SPA Announce an Exclusive Distribution Agreement for the Marketing of Sibnayal in Italy, Spain and Portugal

Sibnayal® will now be available in four of the five major European markets Significant expansion of commercial opportunities for Sibnayal® (potassium citrate/ potassium bicarbonate) Regulatory

Surmodics, Inc. (NASDAQ:SRDX) Q1 2023 Earnings Call Transcript - Vimarsana News

Surmodics, Inc. (NASDAQ:SRDX) Q1 2023 Earnings Call Transcript

Operator: Welcome everyone to Surmodics' First Quarter of Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.